NCT00519844

Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction

Assessment of Satisfaction With Growth Hormone Treatment in Children Born Small for Gestational Age: Benefits of Galenic Form of the Product

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 5 (actual)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: 6 Years – 15 Years
• Healthy volunteers: Not accepted

Summary

This trial is conducted in Europe. The aim of this trial is to assess satisfaction with growth hormone treatment in children of both sexes born small for gestational age and who are receiving growth hormone treatment.

Conditions

• Foetal Growth Problem
• Small for Gestational Age

Interventions

Type	Name	Description
DRUG	somatropin

Timeline

• Start date: 2005-07-01
• Primary completion: 2006-01-01
• Completion: 2006-01-01
• First posted: 2007-08-23
• Last updated: 2015-11-13

Locations

1 site across 1 country: France